RecruitingNot ApplicableNCT05257213

Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy

Intrauterine Adhesions Prevention: the Use of Heparin Solution Compared to Application of Anti-adhesion Barrier Gel After Operative Hysteroscopy

Sponsor

Nadezhda Women's Health Hospital

Enrollment

100 participants

Start Date

Feb 14, 2022

Study Type

INTERVENTIONAL

Conditions

Intrauterine Adhesion

Summary

The aim of this study is to compare the efficacy of intrauterine application of heparin solution to the use of hyaluronic acid barrier gel for the prevention of intrauterine adhesion formation after operative hysteroscopy.

Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Anti-adhesion barrier gel and a drug called Heparin solution for people with intrauterine adhesion. The study is currently recruiting participants at 2 locations. People eligible for this study include women aged 25 Years to 50 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGHeparin solution

3 ml saline solution containing 5000 IU heparin.

DRUGAnti-adhesion barrier gel

2 ml biodegradable barrier gel containing sodium hyaluronate (10 mg/ml), sodium chloride (8.5 mg/ml), disodium hydrogen phosphate (0.34mg/ml), sodium dihydrogen phosphate (0.14 mg/ml) and water for injection (QS to weight).